Biosimulation Market Size Is Anticipated To Reach USD 6.83 Billion by 2028

 Biosimulation Market Growth & Trends

The global biosimulation market size is anticipated to reach USD 6.83 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 15.9% from 2021 to 2028. The key factors fueling the market growth include the increasing incidence of chronic diseases, increase in healthcare digitization, and usage of biosimulation solutions in clinical trials and research.

The need for drug discovery and development amidst the prevalence of acute and chronic diseases has resulted in an increase in the allocation of funds for R&D activities, which has propelled the adoption of biosimulation solutions. In addition, a high drug attrition rate leads to an increase in the cost of clinical trials, which is expected to drive the clinical urgency to incorporate in silico biology approach. This approach significantly reduces the probability of drug failure by predicting biological interactions, thereby reducing the overall costs.

Arise in drug relapse rates, drug resistance cases, and limited availability of drugs to treat diseases such as AIDS have led to high clinical urgency for the adoption of biosimulation in applications, such as drug development and drug discovery.

The COVID-19 pandemic also had a significant impact on the market. Simulations Plus, for instance, launched the StrategiesPlus COVID-19 ACT Program in March 2020 for speeding consulting assistance to any organization involved in the COVID-19 research. As of November 2020, the company declared that its business was not materially adversely affected. However, the continuing spread of COVID-19 and the measures taken by the governments of the affected countries are likely to disrupt the supply chain and adversely impact its business and financial performance.

Surging demand for biosimulation software and services can also be attributed to their higher cost-efficiency. Biosimulation solutions enable cost-effective prediction of toxicity, adverse reactions, and efficacy of investigational drugs during early stages of product development, thus limiting the probability of drug relapse and adverse events at later stages.

Request a free sample copy or view report summary: Biosimulation Market Report

Biosimulation Market Report Highlights

• In terms of product, software dominated the market in 2020. This can be attributed to the availability of a wide range of application-specific software that suits research requirements. Furthermore, biosimulation software is being used in clinical trials and it also eases modeling and target drug identification
• By application, the drug development segment accounted for the largest share in 2020
• Based on end use, pharmaceutical and biotechnology companies dominated the market in 2020 due to increasing strategic initiatives
• North America grabbed the largest share in 2020. The presence of a favorable reimbursement framework (especially post the implementation of the Affordable Care Act) and sophisticated healthcare infrastructure is expected to drive the North American market over the forecast period
• Asia Pacific is expected to grow significantly during the forecast period owing to the increase in the number of CROs, growth in spending on healthcare IT, and rapidly evolving healthcare infrastructure

Access Press Release@ https://www.grandviewresearch.com/press-release/global-biosimulation-market

Biosimulation Market Segmentation

Grand View Research has segmented the global biosimulation market on the basis of product, application, end use, and region:

Biosimulation Product Outlook (Revenue, USD Million, 2016 - 2028)

• Software
• Services
  • In-house Services
  • Contract Services

Biosimulation Application Outlook (Revenue, USD Million, 2016 - 2028)

• Drug Development
• Drug Discovery
• Others

Biosimulation End-use Outlook (Revenue, USD Million, 2016 - 2028)

• Pharmaceutical & Biotechnology Companies
• CROs
• Regulatory Authorities
• Academic Research Institutions

Biosimulation Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
• Asia Pacific
  • Japan
  • China
  • India
• Latin America
  • Mexico
  • Brazil
• MEA
  • South Africa

List of Key Players of Biosimulation Market

• Certara
• DassaultSystemes
• Advanced Chemistry Development
• Simulation Plus
• Schrodinger, Inc.
• Chemical Computing Group ULC
• PhysiomicsPlc
• Rosa & Co. LLC
• BioSimulation Consulting Inc.
• Genedata AG
• Instem Group of Companies
• PPD, Inc. (Evidera)
• Insilico Biotechnology AG
• Immunetrics

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

In-vitro Toxicology Testing Market Growth With Worldwide Industry Analysis To 2028: Grand View Research Inc.

 In-vitro Toxicology Testing Market Growth & Trends

The global in-vitro toxicology testing market size is expected to reach USD 51.1 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 10.7% from 2021 to 2028. In recent times, the validation and acceptance of in-vitro and alternative testing methods by regulatory agencies are increasing at lucrative pace. Also, ongoing technological advancements to replace the use of animals for toxicology testing purposes have spurred the use of in vitro testing models, in turn, driving the market.

Several governments are taking measures to minimize animal-based test models, forming conducive government policies, and providing funds to support in-vitro models. These factors are expected to create ample growth opportunities for the market. For instance, in November 2019, the U.S. National Institute for Environmental Health Sciences planned to provide funds to small companies for the development of engineered 3D culture or organotypic culture models (OCM) in-vitro systems.

With advancements in high throughput screening, biological screening, and chemical synthesis, the number of publicly available databases containing data related to toxicity; absorption, distribution, metabolism, and excretion (ADME); pharmacovigilance; and drug screening has expanded rapidly. This has enabled scientists to access vast information for toxicity profiling, thereby spurring revenue generation in this market. Several companies offer HTT-based in vitro toxicology analysis, e.g., Solidus Bioscience’s MetaChip Technology, which provides a solution for in vitro toxicology analysis using HTT.

Request a free sample copy or view report summary: In-vitro Toxicology Testing Market Report

In-vitro Toxicology Testing Market Report Highlights

• Growing application of 3D-spheroid-cultures, particularly for nanoparticle toxicity testing, resulted in the dominance of the cell culture technology segment in 2020
• Omics technology is anticipated to register lucrative growth over the forecast period as RNA sequencing and shotgun proteomics are increasingly used in research settings
• The cosmetics industry is expected to be the fastest-growing segment in the near future, creating new avenues for the expansion of HTTs across the globe
• The cellular assays segment dominated the market in 2020 owing to advancements in cell-based technologies, including label-free detection and high-content screening
• The potential of cell imaging technologies is combined with high-content cell screening assays and high-throughput assays for the development of multi-parameter assays
• Systemic toxicology emerged as the leading application segment in 2020 as it plays a key role in risk assessment during drug development procedures
• For instance, toxicity testing of systemic immunosuppressive drugs and systemic corticosteroids is important during the development of drugs for ocular inflammatory disease
• The pharmaceutical industry segment dominated the market in 2020 as toxicological testing is a prerequisite step for drug development
• Stringent government regulations regarding animal usage for toxicity analysis in North America have led to an increased adoption rate of in-vitro models
• In Asia Pacific, the market is anticipated to witness the fastest growth rate over the forecast period
• This is due to increasing initiatives by public agencies to encourage acceptance of non-animal test models
• The key participants are involved in collaborations with bioinformatics research firms in order to develop novel in-silicoalgorithms for computational estimation of toxicity of pharmaceutical and chemical products
• Moreover, these market entities are also focusing on entering untapped regions in order to maintain their share in market revenue

Access Press Release@ https://www.grandviewresearch.com/press-release/global-in-vitro-toxicology-testing-market

In-vitro Toxicology Testing Market Segmentation

Grand View Research has segmented the global in-vitro toxicology testing market on the basis of end-use, technology, method, application, and region:

In-vitro Toxicology Testing End-use Outlook, (Revenue, USD Million, 2018 - 2028)

• Pharmaceutical Industry
• Cosmetics & Household Products
• Academic Institutes and Research Laboratories
• Diagnostics
• Chemical Industry
• Food Industry

In-vitro Toxicology Testing Technology Outlook (Revenue, USD Million, 2018 - 2028)

• Cell Culture Technology
• High Throughput Technology
• Molecular Imaging
• OMICS Technology

In-vitro Toxicology Testing Application Outlook, (Revenue, USD Million, 2018 - 2028)

• Systemic Toxicology
• Dermal Toxicity
• Endocrine Disruption
• Occular Toxicity
• Others

In-vitro Toxicology Testing Method Outlook (Revenue, USD Million, 2018 - 2028)

• Cellular Assay
  • Live Cells
    • High Throughput / High Content Screening
    • Molecular Imaging
      • Confocal Microscopy
      • Others
    • Others
  • Fixed Cells
• Biochemical Assay
• In-Silico
• Ex-vivo

In-vitro Toxicology Testing Regional Outlook (Revenue, USD Million, 2018 - 2028)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
• Asia Pacific
  • Japan
  • China
• Latin America
  • Brazil
• Middle East Africa (MEA)
  • South Africa

List of Key Players of In-vitro Toxicology Testing Market

• Merck KGaA
• Charles River
• Bio-Rad Laboratories, Inc.
• Abbott
• Thermo Fisher Scientific Inc.
• Catalent, Inc.
• GE Healthcare
• Quest Diagnostics Incorporated
• Eurofins Scientific
• Laboratory Corporation of America Holdings
• Evotec
• Creative Bioarray
• Gentronix
• BioIVT
• SGS SA
• Agilent Technologies.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Orthopedic Navigation Systems Market to Reach Around USD 6.05 Billion by 2028: Grand View Research Inc.

 Orthopedic Navigation Systems Market Growth & Trends

The global orthopedic navigation systems market size is expected to reach USD 6.05 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 14.4% from 2021 to 2028. The increasing geriatric population prone to orthopedic diseases is a key contributing factor propelling the demand for orthopedic navigation systems. Osteoarthritis and osteoporosis are the most common disorders in the population aged 70 years and above. The growing prevalence of these disorders results in an increased economic burden on many countries.

Due to the COVID-19 pandemic, non-emergency procedures were canceled or postponed, which adversely affected the global market as restrictions resulted in delays to a number of procedures. In the U.K., the number of individuals waiting for surgical procedures has increased to approximately 10 million from 4 million before the pandemic. While the U.S. is expected to have a backlog of more than 1 million joint and spinal surgeries by mid-2022. Currently, most nations have elevated restrictions on elective surgery. As a result of the recommencement of surgical procedures at full force, the market is anticipated to catch up the pace over the forecast years.

Rising awareness about the benefits of minimally invasive surgery is expected to further boost the product demand in the coming years. Some of the benefits include less blood loss, reduced risk of damage, condensed risk of infection and postoperative pain, and quicker recovery from surgery. In addition, the introduction of technologically advanced products is boosting market growth. For instance, in July 2021, SeaSpine Holdings Corp. broadcasted the FDA 510(k) authorization for its 7D Percutaneous Spine Module. This module is for minimally invasive surgery. This signifies a novel application and improved functionality for its 7D Flash Navigation System.

Request a free sample copy or view report summary: Orthopedic Navigation Systems Market Report

Orthopedic Navigation Systems Market Report Highlights

• The knee segment accounted for the largest revenue share in 2020 owing to the rising prevalence of osteoarthritis, which is the most common form of arthritis and the leading cause of chronic pain and physical disability in elder persons
• The spine segment is anticipated to witness the fastest CAGR from 2021 to 2028 due to the rising incidence of spinal deformities
• According to a CDC report, in 2019, around 34.0% of the adult population and 62.0% of the elderly population were affected by spinal deformities
• The optical navigation system segment held the largest revenue share in 2020 owing to the affordability of the technology as compared to other navigation systems
• The hospitals segment held the largest revenue share in 2020. Hospitals use technologically advanced medical devices to improve the Point-of-Care (PoC), which drives segment growth
• North America dominated the global market in 2020 due to the availability of better-quality healthcare infrastructure and favorable government initiatives
• The market is highly competitive as major players are focusing more on the product innovation strategies due to changing needs of healthcare establishments, surgeons, and patients
• The market is moving toward consolidation as large companies are focused on strategic acquisitions of smaller companies to gain a competitive advantage

Access Press Release@ https://www.grandviewresearch.com/press-release/global-orthopedic-navigation-systems-market

Orthopedic Navigation Systems Market Segmentation

Grand View Research has segmented the global orthopedic navigation systems market on the basis of application, technology, end-use, and region:

Orthopedic Navigation Systems Application Outlook (Revenue, USD Million, 2016 - 2028)

• Knee
• Hip
• Spine

Orthopedic Navigation Systems Technology Outlook (Revenue, USD Million, 2016 - 2028)

• Electromagnetic
• Optical
• Others

Orthopedic Navigation Systems End-use Outlook (Revenue, USD Million, 2016 - 2028)

• Hospitals
• Ambulatory Surgical Centers (ASCs)

Orthopedic Navigation Systems Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Switzerland
  • Italy
  • Spain
  • Belgium
  • Austria
  • The Netherlands
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
• Middle East and Africa
  • South Africa

List of Key Players of Orthopedic Navigation Systems Market

• Braun Melsungen AG
• Stryker
• Medtronic
• Smith+Nephew
• Johnson & Johnson Services, Inc. (DePuy Synthes)
• Zimmer Biomet
• Amplitude Surgical
• Kinamed, Inc.
• Globus Medical
• OrthAlign

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

𝐃𝐢𝐠𝐢𝐭𝐚𝐥 𝐒𝐢𝐠𝐧𝐚𝐠𝐞 - 𝐓𝐡𝐞 𝐋𝐚𝐭𝐞𝐬𝐭 𝐓𝐫𝐞𝐧𝐝𝐬 𝐀𝐧𝐝 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬

 

Know More- https://www.grandviewresearch.com/industry-analysis/digital-signage-market

Rising demand for advanced products that require digitized information management and guidance and can be accessed from remote locations. This is also among the key factors anticipated to boost the global market growth during the forecast period. With digitized display technology, information is provided in a digitized format that includes motion and pictures to promote a business more effectively than the traditional modes of reaching out to customers. Moreover, the integration of biometric technology with modern digitized signs has developed products, such as track heat paths and gaze tracking. 

𝐂𝐡𝐚𝐭𝐛𝐨𝐭 𝐓𝐡𝐞 𝐍𝐞𝐱𝐭 𝐁𝐢𝐠 𝐓𝐡𝐢𝐧𝐠

Know More@ https://www.grandviewresearch.com/industry-analysis/chatbot-market

A chatbot is an interactive application developed using either a set of rules or artificial intelligence technology. It is designed to interact with humans through the textual conversation process and is integrated with various messaging services, thereby assisting users in various sectors. Various innovations carried out in Artificial Intelligence (AI), and Machine Learning (ML) technologies are expected to enhance the features of chatbots, which, in turn, would drive demand.

 

Pulse Oximeter Market to Record an Exponential CAGR by 2028: Grand View Research Inc.

 Pulse Oximeter Market Growth & Trends

The global pulse oximeter market size is expected to reach USD 3.4 billion by 2028, based on a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 6.4% from 2021 to 2028. Technological advancements in products, growing healthcare costs, and readmission, and increasing adoption of pulse oximetry devices are expected to boost market growth during the forecast period. Market players are introducing devices that are more efficient and support telehealth approaches. For instance, in February 2017, the company received a CE mark for Rad-97 Pulse CO-Oximeter used to monitor blood pressure at set intervals. It is also capable of transferring the data to a remotely connected device.

There are various other types of oximeters such as wrist-worn oximeters, bedside, or desktop oximeters, and mobile phone pulse oximeters, the latest addition. These oximetry devices are equipped with a sensor that is compatible with the software installed in a user’s mobile phone, which analyzes data to display information. For instance, iHealth Labs, a subsidiary of a China-based company, Andon Health, offers such products. In October 2013, the company received FDA approval for its wireless pulse oximetry device.

Request a free sample copy or view report summary: Pulse Oximeter Market Report

Pulse Oximeter Market Report Highlights

• The fingertip pulse oximetry devices are being used by customers to self-monitor symptoms of COVID-19 contributing to segment growth since the onset of the pandemic
• In handheld pulse oximetry devices, the probe, which is very delicate and prone to damage, can be replaced, unlike in fingertip oximeters, and is expected to be in high demand due to the advantage of reduced risk of COVID-19 transmission
• There is an upward trend in the use of the medical device in homecare settings as it enables tracking and storing of patient's oxygen level readings, which reduces the need for hospital readmissions
• North America held the largest share in the market in 2020 due to factors such as availability of funds for R&D. The sales for fingertip pulse oximetry devices soared in January 2020 and March 2020 in the U.S. post the country-wide spread of the novel coronavirus and release of the WHO guidelines citing the oximeter as an essential device for monitoring blood oxygen during self-management
• In Asia Pacific, the demand for medical devices has increased from hospitals for monitoring critically ill COVID-19 patients. As the spread of the novel coronavirus has progressed significantly, the Ministry of Health and Family Welfare in India has notified all healthcare facilities to make necessary arrangements for devices used in diagnostics, treatment, and management of Severe Acute Respiratory Syndrome (SARS)
• The industry is also witnessing mergers, acquisitions, and licensing agreements. For instance, in December 2016, Nihon Kohden announced an absorption-type merger of 11 wholly-owned consolidated subsidiaries to improve management and efficiency of operations

Access Press Release@ https://www.grandviewresearch.com/press-release/global-pulse-oximeters-market

Pulse Oximeter Market Segmentation

Grand View Research has segmented the global pulse oximeter market on the basis of type, end-use, and region:

Pulse Oximeters Type Outlook(Revenue, USD Million, 2016 - 2028)

• Fingertip
• Handheld
• Others

Pulse Oximeters End-use Outlook(Revenue, USD Million, 2016 - 2028)

• Hospitals & Other Healthcare Facilities
• Homecare

Pulse Oximeters Regional Outlook(Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
• Asia Pacific
  • China
  • Japan
  • India
• Latin America
  • Brazil
  • Mexico
• Middle East & Africa (MEA)
  • South Africa

List of Key Players of Pulse Oximeters Market

• Medtronic (Covidien)
• Carefusion Corp.
• GE Healthcare
• Philips Healthcare
• Masimo
• CAS Medical Systems, Inc.
• Opto Circuits India Ltd.
• Nonin Medical, Inc.
• Smiths Medical
• Welch Allyn
• Spacelabs Healthcare
• Meditech Equipment Co.
• Nihon Kohden Corporation

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Diabetes Devices Market Forecast 2028 Top Companies, Trends and Growth Factors Details for Business Development

 Diabetes Devices Market Growth & Trends

The global diabetes devices market size is expected to reach USD 44.6 billion by 2028, registering a CAGR of 6.6% over the forecast period, according to a new report by Grand View Research, Inc. The market is driven by factors such as increasing incidence of diabetes, technological advancements, and innovative product launches. Increasing adoption of advanced diabetes management solutions in developing region, government policies, and rising medical tourism are some of the major factors contributing to the market growth. Furthermore, rising government initiatives to spread awareness about diabetes and increasing R&D expenditure of major players are the factors expected to boost the market growth.

According to a study published on National Center for Biotechnology Information (NCBI), global health expenditure on diabetes is expected to reach USD 490 billion in 2030 from 376 billion in 2010. Obesity, sedentary lifestyle, and fast food culture are some of the factors expected to have significant impact on the market growth. According to Harvard T.H. Chan School of Public Health, U.S. has the highest rates of obesity and it is expected to increase up to 50% by 2030.

In addition, increasing number of new market players, who focus on patient convenience with the help of artificial intelligence technology, are also transforming the market. They are leveraging technological advancements to improve diabetes care solutions like CGM devices, non-invasive insulin delivery systems, and digital diabetes management platforms. For instance, in December 2017, Companion Medical Launched Inpen, its first smart insulin pen system in the U.S. It is the only FDA-approved device that can combine insulin injector pen with a smart app.

Request a free sample copy or view report summary: Diabetes Devices Market Report

Diabetes Devices Market Report Highlights

• North America accounted for the largest share in 2019, in terms of revenue, owing to favorable reimbursement policies, presence of key players, and frequent product launches
• By product, the insulin delivery devices segment accounted for the largest market share and is also expected to grow at the fastest rate
• In the Blood Glucose Monitoring (BGM) segment, self-monitoring devices dominated the market owing to their low cost and high usage
• In Self-monitoring of Blood Glucose (SMBG) devices, testing strips segment dominated the market while blood glucose meters are expected to grow at a significant pace owing to high adoption and technological advancements
• In the Continuous Glucose Monitoring (CGM) devices segment, transmitters accounted for the largest share owing to high cost of devices and high usage
• In insulin delivery devices, pens segment dominated the market since it is easy to carry, easy to use, and has low cost as compared to other delivery devices
• By distribution channel, hospital pharmacy segment dominated the market owing to rise in sales of diabetes devices in these pharmacies
• By end use, hospital segment accounted for the largest market share owing to improving healthcare infrastructure due to rising investment
• The leading players present in the diabetes devices market are Medtronic plc; Abbott Laboratories; F.Hoffmann-La-Ltd; Bayer AG; Lifescan, Inc.; B Braun Melsungen AG; Lifescan, Inc.; Dexcom Inc.; Insulet Corporation; Ypsomed Holdings; Companion Medical; Sanofi; Valeritas Holding Inc.; Novo Nordisk; Arkray, Inc.; among others.

Access Press Release@ https://www.grandviewresearch.com/press-release/global-diabetes-devices-market

Diabetes Devices Market Segmentation

Grand View Research has segmented global diabetes devices market on the basis of type, distribution channel, end-use, and region:

Diabetes Devices Type Outlook (Revenue, USD Million, 2016 - 2028)

• BGM Devices
  • Self-Monitoring Devices
    • Blood Glucose Meters
    • Testing Strips
    • Lancets
  • Continuous Glucose Monitoring Devices
    • Sensors
    • Transmitters
    • Receiver
  • Insulin Delivery Devices
    • Pumps
    • Pens
    • Syringes
    • Jet Injectors

Diabetes Devices Distribution Channel Outlook (Revenue, USD Million, 2016 - 2028)

• Hospital pharmacies
• Retail Pharmacies
• Diabetes Clinics/Centers
• Online Pharmacies
• Others

Diabetes Devices End-use Outlook (Revenue, USD Million, 2016 - 2028)

• Hospitals
• Homecare
• Diagnostic Centers

Diabetes Devices Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Spain
  • Italy
  • Russia
  • Czech Republic
  • Poland
  • Switzerland
  • Turkey
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • Vietnam
  • Philippines
  • Malaysia
  • Indonesia
  • Thailand
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Chile
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Egypt
  • Oman

List of Key Players of Diabetes Devices Market

• Medtronic plc
• Abbott Laboratories
• Hoffmann-La-Ltd.
• Bayer AG
• Lifescan, Inc.
• B Braun Melsungen AG
• Lifescan, Inc.
• Dexcom Inc.
• Insulet Corporation
• Ypsomed Holdings
• Companion Medical
• Sanofi
• Valeritas Holding Inc.
• Novo Nordisk
• Arkray, Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Craniomaxillofacial Devices Market Expected To Propel Industry Growth At CAGR of 9.0% Through 2028: Grand View Research Inc.

 

Craniomaxillofacial Devices Market Growth & Trends

The global craniomaxillofacial devices market size is expected to reach USD 3.2 billion by 2028 registering a CAGR of 9.0% over the forecast period, according to a new report by Grand View Research, Inc. Craniofacial surgery treats conditions that affect the head, skull, face, and neck. The rise in the number of facial and head injuries caused due to road accidents and increasing cases of sports-related injuries are expected to boost demand for craniomaxillofacial (CMF) devices.

Growingpreferencefor minimally invasive surgeries is also one of the key factors expected to support market growth. Organizations, such as the American Society of Craniofacial Surgery (ASCFS) and the International Society of Craniofacial Surgery (ISCFS), are conducting a research program in a probe to increase awareness of CMF surgeries, boosting consumer awareness about the craniomaxillofacial devices. This is also projected to help boost the overall market growth.

Neck injuries are one of the most common types of injuries in vehicle accidents. Over 800, 000 cases of vehicle crashes involving neck injuries are reported per year in the U.S. Moreover, sports injuries, car accidents, and falls were some of the leading causes of head injuries in the country. Hence, the U.S. is expected to be a potential market for CMF device manufacturers. The global pandemic has led to the cancellation and rescheduling of surgical procedures, which will hamper the market growth to some extent.

Request a free sample copy or view report summary: Craniomaxillofacial Devices Market Report

Craniomaxillofacial Devices Market Report Highlights

• In 2020, the CMF plate and screw fixation segment led the global market due to the rise in the number of surgeries requiring bone stabilization
• The bioabsorbable material segment is estimated to register the fastest CAGR during the forecasted period due to technological advancements
• Neurosurgery & ENT is expected to be the fastest-growing application segment from 2021 to 2028 due to an increase in the volume of surgical procedures pertaining to trauma and the adoption of deep brain stimulation procedures
• Latin American region is projected to be the fastest-growing regional market during the forecast period on account of rising cases of accidents in Brazil and Mexico

Access Press Release@ https://www.grandviewresearch.com/press-release/global-cmf-devices-market

Craniomaxillofacial Devices Market Segmentation

Grand View Research has segmented the global craniomaxillofacial devices market on the basis of product, material, application, and region:

CMF Devices Product Outlook (Revenue, USD Million, 2016 - 2028)

• Cranial Flap Fixation
• CMF Distraction
• Temporomandibular Joint Replacement
• Thoracic Fixation
• Bone Graft Substitute
• CMF Plate & Screw Fixation

CMF Devices Material Outlook (Revenue, USD Million, 2016 - 2028)

• Metal
• Bioabsorbable Material
• Ceramics

CMF Devices Application Outlook (Revenue, USD Million, 2016 - 2028)

• Neurosurgery & ENT
• Orthognathic & Dental Surgery
• Plastic Surgery

CMF Devices Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
  • Russia
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • Singapore
  • Malaysia
• Latin America
  • Brazil
  • Mexico
• MEA
  • South Africa
  • Saudi Arabia

List of Key Players of Craniomaxillofacial Devices Market

• DePuy Synthes (J&J)
• Stryker Corp.
• Medtronic plc
• Zimmer Biomet

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Ambulance Services Market is Anticipated To Incur The Fastest Growth with a CAGR of 9.6% by 2028: Grand View Research Inc.

 

Ambulance Services Market Growth & Trends

The global ambulance services market size is expected to reach USD 67.7 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 9.6% from 2021 to 2028. Rising medical tourism and an increasing number of road accidents and CVD cases are the key driving factors for the market.

The growth of the market is due to favorable reimbursement policies in developed nations. In the U.S., Medicare covers both non-emergency and emergency ambulance services for medically necessary cases, if the supplier fulfills stipulated requirements. In some circumstances, Medicare also covers unscheduled and irregular non-emergency trips. Medicare covers 80.0% of the approved amount for emergency medical services and the remaining 20.0% is covered by the supplemental insurance policy of the patient. In New Jersey, Pennsylvania, and South Carolina, for repetitive, non-emergency trips, patients need prior authorization from Medicare Administrative Contractor (MAC). However, Medicare does not pay for ambulates (wheelchair-accessible vans that provide non-emergency transportation services).

In Victoria, Australia, patients can avail of emergency medical services by securing membership with Ambulance Victoria, which offers emergency medical services at subsidized prices. Ambulance Tasmania provides free emergency medical services to residents of Tasmania. Residents of Queensland (Australia) are covered with the cost of emergency services across Australia, by the QLD state government. Similarly, in the U.K., the public healthcare system provides free emergency and non-emergency medical services. In addition, patients receive NHS funding for their treatment. In Germany, public health insurance (Gesetzliche Krankenversicherung) is compulsory for every citizen and this insurance also covers non-emergency and emergency medical services. Private health insurance (Private Krankenversicherung) is usually opted by those who have high yearly income. Ease of payment through reimbursement policies encourages patients to opt for emergency medical services more frequently, which is likely to bolster the growth of the market.

Request a free sample copy or view report summary: Ambulance Services Market Report

Ambulance Services Market Report Highlights

• In terms of revenue, the ground ambulance segment held the largest share in 2020. The rising number of road accidents and increasing COVID-19 cases across the globe are major factors propelling segment growth
• The emergency services segment held the largest market share in 2020 and is expected to grow fast over the forecast period due to the increasing number of CVDs
• The Advanced Life Support (ALS) ambulance services segment held the largest market share in 2020. The growth of the segment is majorly driven by the increasing medical tourism across the globe
• In Asia Pacific, the market is expected to witness the fastest growth rate over the forecast period owing to the rising number of COVID-19 cases in the region

Access Press Release@ https://www.grandviewresearch.com/press-release/global-ambulance-services-market

Ambulance Services Market Segmentation

Grand View Research has segmented the global ambulance services market on the basis of transport vehicle, equipment, emergency services, and region:

Ambulance Services Transport Vehicle Outlook (Volume, Units; Revenue, USD Million, 2016 - 2028)

• Ground Ambulance
• Air Ambulance
• Water Ambulance

Ambulance Emergency Services Outlook (Volume, Units; Revenue, USD Million, 2016 - 2028)

• Emergency Services
• Non-emergency Services

Ambulance Services Equipment Outlook (Volume, Units; Revenue, USD Million, 2016 - 2028)

• Advanced Life Support (ALS) Ambulance Services
• Basic Life Support (BLS) Ambulance Services

Ambulance Services Regional Outlook (Volume, Units; Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
  • France
  • Italy
  • Spain
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
• Middle East & Africa
  • South Africa
  • Saudi Arabia

List of Key Players of Ambulance Services Market

• Envision Healthcare
• London Ambulance Service NHS Trust
• Acadian Ambulance Service
• BVG India Limited
• America Ambulance Services, Inc.
• Falck Denmark A/S
• Air Medical Group Holdings, Inc. (AMGH)
• Air Methods Corporation
• Ziqitza Healthcare Limited
• Medivic Aviation

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

HPV Testing And Pap Test Market Size Likely To Reach $7.3 Billion By 2028: Grand View Research Inc.

 

HPV Testing And Pap Test Market Growth & Trends

The global HPV testing and Pap test market size is expected to reach USD 7.3 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 16.4% from 2021 to 2028. The introduction of innovative tests, increasing awareness programs, rising public-private investments, and high incidence of HPV infections are some of the factors anticipated to foster market growth during the forecast period.

Cervical cancer is a global problem, affecting millions of women. As per the Globocan estimates, in 2020, around 604,127 new cases of the cervix and uterine cancer were diagnosed globally, which led to around 341,831 deaths in the same year. According to the WHO, 99% of cervical cancer cases are linked with HPV infection. Such a high incidence and mortality rate of the disease has created a major demand for innovative and accurate screening for early detection and management. In addition, approval of novel testing solutions and services to upsurge screening rates is further anticipated to support market growth. In April 2020, Roche received FDA approval for its cobas HPV screening to be used on cobas 6800/8800 Systems, a fully automated and high-throughput system. Also, in February 2019, the Japanese company CMIC Healthcare Co., Ltd. launched SelCheck Cervical Cancer, a self-collect HPV test service focused on increasing the frequency of screening rates in the country.

The outbreak of novel coronavirus (COVID-19) and nationwide lockdowns due to it in key geographies has drastically reduced the routine cervical cancer screening procedures. According to data published by the CDC, due to stay-at-home orders, the cervical cancer screening rate decreased by around 80% in California, U.S. Thus, such decreased testing rates have negatively affected the overall revenue growth of the market in 2020. However, increasing government initiatives to control the reducing testing rates is anticipated to offset the impact of COVID-19 in the near future. For instance, in February 2021, NHS England initiated a trial and offered at-home HPV testing kits to more than 31,000 women to carry out screening in the privacy and convenience of their own homes. This trial aims to increase the HPV screening rate in the country.

Request a free sample copy or view report summary: HPV Testing And Pap Test Market Report

HPV Testing And Pap Test Market Report Highlights

• Based on test type, the Pap test segment accounted for the largest revenue share in 2020, owing to its widespread use in cervical cancer screening programs
• By application, the cervical cancer screening segment dominated the market in 2020, due to its higher incidence and mortality rates
• By product type, the consumables segment dominated the market in 2020, owing to its repetitive use to conduct testing in hospitals and laboratories
• The PCR segment is projected to show the fastest growth rate in the technology segment, owing to the enactment of new recommendations to use DNA HPV testing
• In Asia Pacific, the market is expected to witness lucrative growth as a result of the growing demand for HPV and Pap tests from emerging economies, such as China and India, which have a huge target population

Access Press Release@ https://www.grandviewresearch.com/press-release/global-hpv-test-pap-test-market

HPV Testing And Pap Test Market Segmentation

Grand View Research has segmented the global HPV testing and Pap test market on the basis of test type, application, product, technology, end-use, and region:

HPV Testing & Pap Test Type Outlook (Revenue, USD Million, 2016 - 2028)

• HPV Testing
• Pap Test

HPV Testing & Pap Test Application Outlook (Revenue, USD Million, 2016 - 2028)

• Cervical Cancer Screening
• Vaginal Cancer Screening

HPV Testing & Pap Test Product Outlook (Revenue, USD Million, 2016 - 2028)

• Instruments
• Consumables
• Services

HPV Testing & Pap Test Technology Outlook (Revenue, USD Million, 2016 - 2028)

• PCR
• Immunodiagnostics
• Other Technologies

HPV Testing & Pap Test End-use Outlook (Revenue, USD Million, 2016 - 2028)

• Hospitals & Clinics
• Laboratories
• Others

HPV Testing & Pap Test Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
  • France
  • Italy
  • Spain
  • Russia
• Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Australia
  • Singapore
• Latin America
  • Brazil
  • Mexico
  • Argentina
• MEA
  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players of HPV Testing And Pap Test Market

• Abbott Laboratories
• Qiagen N.V.
• Becton, Dickinson and Company
• Quest Diagnostics, Inc.
• Hologic, Inc.
• Hoffmann-La Roche
• Femasys, Inc.
• Arbor Vita Corporation
• NURX, Inc.
• Seegene, Inc.
• Thermo Fisher Scientific, Inc.
• bioMérieux SA

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

𝐓𝐞𝐥𝐞𝐜𝐨𝐦 𝐒𝐞𝐫𝐯𝐢𝐜𝐞𝐬: 𝐁𝐫𝐨𝐚𝐝𝐛𝐚𝐧𝐝 𝐁𝐨𝐨𝐦

 

𝐊𝐧𝐨𝐰 𝐌𝐨𝐫𝐞- https://www.grandviewresearch.com/industry-analysis/global-telecom-services-market

Rising spending on the deployment of 5G infrastructures due to the shift in customer inclination toward next-generation technologies and smartphone devices is one of the key factors driving this industry. An increasing number of mobile subscribers, soaring demand for high-speed data connectivity, and the growing demand for value-added managed services are the other potential factors fueling the market growth. The global communication network has undoubtedly been one of the prominent areas for continued technological advancements over the past few decades.

𝐁𝐥𝐨𝐜𝐤𝐜𝐡𝐚𝐢𝐧 𝐓𝐞𝐜𝐡𝐧𝐨𝐥𝐨𝐠𝐲 : 𝐓𝐡𝐞 𝐁𝐞𝐠𝐢𝐧𝐧𝐢𝐧𝐠 𝐨𝐟 𝐚 𝐍𝐞𝐰 𝐄𝐫𝐚 𝐢𝐧 𝐓𝐫𝐚𝐜𝐞𝐚𝐛𝐢𝐥𝐢𝐭𝐲

 

Know More@ https://www.grandviewresearch.com/industry-analysis/blockchain-technology-market

Blockchain has emerged as a highly promising technology in the IT domain. It is an open, immutable, distributed public ledger that can be accessed by several parties involved in the transaction and acts as a universal depository of all transactions between the involved parties. The increasing acceptance of cryptocurrency worldwide is one of the major factors driving market growth. Commercial and central banks across the world are now using blockchain technology for payment processing and issuing of their digital currencies. The technology enables cross-border payments that are less expensive and faster as compared to traditional systems.

Clinical Trials Market Size Is Expected To Reach USD 69.3 Billion by 2028

 Clinical Trials Market Growth & Trends

The global clinical trials market size is expected to reach USD 69.3 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 5.7% from 2021 to 2028. An increase in the volume and complexity of clinical trials has been witnessed lately, which plays an important role in the R&D of new drugs and other products. The market witnessed a decline of 6.0% in 2020 owing to the COVID-19 pandemic. However, the market is projected to recover from 2021 onwards. Also, clinical trials have become increasingly costly ventures, adding to the overall cost of developing a drug. Hence, big pharmaceuticals and small biotechnology firms are looking for innovative ways to improve trial outcomes and decrease operational costs.

The increasing need to develop new therapeutics for chronic diseases such as cancer, respiratory disorder, diabetes, cardiovascular disease, and others is creating immense pressure on healthcare. The global pandemic caused due to COVID-19 and the increasing demand for developing a suitable treatment for the same is driving the market’s growth. The number of people affected by the coronavirus has reached one million, which further depicts an increasing need for therapeutics and vaccines. Currently, there are 288therapeutics and 106 vaccines in development. Out of this, nearly 7.0% of therapeutics are in Phase IV, 21.0% in Phase III, and 43.0% and 13.0% in Phase II and Phase I respectively.

The pandemic has also resulted in the global disruption of traditional onsite clinical trials. Hence, regulatory bodies all over the world have launched various initiatives for fast-tracking clinical trials for the development of innovative solutions. One such instance is Solidarity, an international clinical trial launched by the WHO to find effective treatment against COVID-19.

Though COVID-19 is forcing many medical device and drug developers to revise the approach they prepare for these types of crises, integrating best practices within clinical trial procedures and adapting to virtual trials can support the continuous development of therapeutics even in the presence of this pandemic.

Request a free sample copy or view report summary: Clinical Trials Market Report

Clinical Trials Market Report Highlights

• The phase III segment dominated the market and accounted for the largest revenue share of 53.2% in 2020. This is attributed to the complexity level associated with this phase
• The interventional segment accounted for the largest revenue share of 82.1% in 2020 owing to the increasing demand for the intervention for clinical trials by researchers
• North America dominated the market and accounted for the largest revenue share of 51.0% in 2020. Favorable government initiatives and the presence of large numbers of players in the U.S. offerings advanced services are responsible for market growth
• In Asia Pacific, the market is expected to expand at the fastest CAGR of 6.7% over the forecast period owing to the increasing patient pool and cost-efficient services

Access Press Release@ https://www.grandviewresearch.com/press-release/clinical-trials-market

Clinical Trials Market Segmentation

Grand View Research has segmented the global clinical trials market based on phase, study design, indication, indication by study design, and region:

Clinical Trials Phase Outlook (Revenue, USD Million, 2016 - 2028)

• Phase I
• Phase II
• Phase III
• Phase IV

Clinical Trials Study Design Outlook (Revenue, USD Million, 2016 - 2028)

• Interventional
• Observational
• Expanded Access

Clinical Trials Indication Outlook (Revenue, USD Million, 2016 - 2028)

• Autoimmune/Inflammation
  • Rheumatoid arthritis
  • Multiple sclerosis
  • Osteoarthritis
  • Irritable Bowel Syndrome (IBS)
  • Others
• Pain management
  • Chronic pain
  • Acute pain
• Oncology
  • Blood cancer
  • Solid tumors
  • Other
• CNS condition
  • Epilepsy
  • Parkinson's Disease (PD)
  • Huntington's Disease
  • Stroke
  • Traumatic Brain Injury (TBI)
  • Amyotrophic Lateral Sclerosis (ALS)
  • Muscle regeneration
  • Others
• Diabetes
• Obesity
• Cardiovascular
• Others

Clinical Trials Indication By Study Design Outlook (Revenue, USD Million, 2016 - 2028)

• Autoimmune/Inflammation
  • Interventional
  • Observational
  • Expanded Access
• Pain management
  • Interventional
  • Observational
  • Expanded Access
• Oncology
  • Interventional
  • Observational
  • Expanded Access
• CNS condition
  • Interventional
  • Observational
  • Expanded Access
• Diabetes
  • Interventional
  • Observational
  • Expanded Access
• Obesity
  • Interventional
  • Observational
  • Expanded Access
• Cardiovascular
  • Interventional
  • Observational
  • Expanded Access
• Others
  • Interventional
  • Observational
  • Expanded Access

Clinical Trials Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Spain
  • Italy
• Asia Pacific
  • India
  • Japan
  • China
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players of Clinical Trials Market

• ICON Plc
• Wuxi AppTec
• PRA Health Sciences
• SGS SA
• Syneos Health
• Eli Lilly and Company
• Novo Nordisk A/S
• Pfizer
• Clinipace

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.